Literature DB >> 21521277

A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population.

Inge B Pedersen1, Nils Knudsen, Allan Carlé, Pernille Vejbjerg, Torben Jørgensen, Hans Perrild, Lars Ovesen, Lone B Rasmussen, Peter Laurberg.   

Abstract

UNLABELLED: Autoantibodies against the thyroid gland with thyroid peroxidase antibody (TPO-Ab) and thyroglobulin antibody (Tg-Ab) as the most common can often be demonstrated in serum. The effect of public iodization programmes on antibody prevalence is uncertain. AIM: To measure the concentrations of thyroid autoantibodies in the Danish population before and after mandatory iodization of salt.
METHODS: Two identical cross-sectional population studies were performed before (Cohort 1 (C1), year 1997-1998, n = 4649, median urinary iodine 61 μg/l) and 4-5 years after (Cohort 2 (C2), year 2004-2005, n = 3570, median urinary iodine 101 μg/l) mandatory iodine fortification of salt was implemented in Denmark. Blood tests were analysed for TPO-Ab and Tg-Ab using sensitive assays.
RESULTS: Antibodies were more frequent in C2 than in C1: TPO-Ab > 30 U/ml, C1 vs C2: 14·3 vs 23·8% (P < 0·001) and Tg-Ab > 20 U/ml, C1 vs C2: 13·7 vs 19·9% (P < 0·001). The C2 vs C1 effect was confirmed in multivariate regression models (C1 reference): TPO-Ab: OR (95% CI): 1·80 (1·59-2·04) and Tg-Ab: 1·49 (1·31-1·69). The increase in the frequency of thyroid antibodies was most pronounced in young women and especially observed at low concentrations of antibodies.
CONCLUSION: The prevalence of both TPO-Ab and Tg-Ab was higher 4-5 years after a cautious iodine fortification of salt was introduced in Denmark. The increase was most pronounced in young women and in the low concentrations of antibody. Further studies are needed to evaluate the long-term effects of increased iodine intake on thyroid autoimmunity in the population.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521277     DOI: 10.1111/j.1365-2265.2011.04008.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  33 in total

Review 1.  The incidence and prevalence of thyroid autoimmunity.

Authors:  Donald S A McLeod; David S Cooper
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Authors:  L Tomisti; C Urbani; G Rossi; F Latrofa; C Sardella; L Manetti; I Lupi; C Marcocci; L Bartalena; O Curzio; E Martino; F Bogazzi
Journal:  J Endocrinol Invest       Date:  2016-01-13       Impact factor: 4.256

3.  Autoimmunity: effect of an iodization program on thyroid autoantibody prevalence.

Authors:  Carol Wilson
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

4.  Doubling in the use of thyroid hormone replacement therapy in Denmark: association to iodization of salt?

Authors:  Charlotte Cerqueira; Nils Knudsen; Lars Ovesen; Peter Laurberg; Hans Perrild; Lone Banke Rasmussen; Torben Jørgensen
Journal:  Eur J Epidemiol       Date:  2011-06-10       Impact factor: 8.082

5.  Iodine, thyroid autoimmunity and cancer.

Authors:  Emilio Fiore; Francesco Latrofa; Paolo Vitti
Journal:  Eur Thyroid J       Date:  2015-03-03

Review 6.  Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns.

Authors:  Elizabeth N Pearce; John H Lazarus; Rodrigo Moreno-Reyes; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

Review 7.  Global epidemiology of hyperthyroidism and hypothyroidism.

Authors:  Peter N Taylor; Diana Albrecht; Anna Scholz; Gala Gutierrez-Buey; John H Lazarus; Colin M Dayan; Onyebuchi E Okosieme
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

8.  TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001).

Authors:  Ilaria Muller; Lucy S Kilburn; Peter N Taylor; Peter J Barrett-Lee; Judith M Bliss; Paul Ellis; Marian E Ludgate; Colin M Dayan
Journal:  Eur Thyroid J       Date:  2017-04-04

9.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

Review 10.  Iodine Supplementation in Pregnancy and the Dilemma of Ambiguous Recommendations.

Authors:  Stine Linding Andersen; Peter Laurberg
Journal:  Eur Thyroid J       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.